Wiki/BiographyJing Ulrich (Chinese: 李晶; b. 1967, Li Jing in Beijing, née Li, China) is the managing director and vice chairman of Asia Pacific at JPMorgan Chase. Ulrich is one of the most prominent advisors to the largest global asset-management companies, sovereign-wealth funds, and multinational corporations. She is in charge of covering JPMorgan Chase's most senior global clients across all asset classes and strengthening relationships with executives in Asia Pacific and the rest of the world. In recent years, various publications have listed her among the world's most powerful women. For example, in October 2013, Fortune Magazine for the fourth time, ranked Ulrich among the top 50 most powerful global businesswomen, and in July 2014, Forbes Magazine listed her among its China Power Women. Likewise, in October 2013, the South China Morning Post featured Ulrich as one of Hong Kong's 25 most inspirational and influential women, who have made a difference to society.Ulrich also created and runs JPMorgan's "Hands-on China" series of expert speakers, which has become a leading platform of views on all aspects of China’s development, and she has hosted hundreds of corporate CEOs, industry experts, and thought leaders at seminars and meetings worldwide. Each year she organizes a China-investent summit that brings together, from forty countries, over two thousand fund managers, corporate executives, and outside experts to discuss opportunities for investing in China. Previous conferences run by Ulrich have included keynote speeches by former officials such as Chinese Premier Zhu Rongji, U.S. President Bill Clinton, Secretary of State Henry Kissinger, and U.K. Prime Minister Tony Blair.In 2014, in addition to her duties at JPMorgan, Ulrich was appointed to the Asia Pacific Economic Cooperation (APEC) China Business Council Multinational Advisory Committee. She also joined a roster of prominent international figures on the International Advisory Council of Bocconi University in Italy. Moreover, Ulrich has served as an independent director on the boards of GlaxoSmithKline, a global healthcare company, and Italian luxury-goods firm, Ermenegildo Zegna.